Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1992 1
1993 1
1995 1
1996 1
2000 1
2002 1
2003 2
2004 1
2009 1
2010 2
2014 1
2015 1
2016 1
2017 2
2018 1
2020 1
2021 1
2022 1
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

23 results
Results by year
Filters applied: . Clear all
Page 1
Autophagy Is Differentially Regulated in Leukocyte and Nonleukocyte Foam Cells During Atherosclerosis.
Robichaud S, Rasheed A, Pietrangelo A, Doyoung Kim A, Boucher DM, Emerton C, Vijithakumar V, Gharibeh L, Fairman G, Mak E, Nguyen MA, Geoffrion M, Wirka R, Rayner KJ, Ouimet M. Robichaud S, et al. Among authors: boucher dm. Circ Res. 2022 Mar 18;130(6):831-847. doi: 10.1161/CIRCRESAHA.121.320047. Epub 2022 Feb 9. Circ Res. 2022. PMID: 35137605 Free article.
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.
Market M, Angka L, Martel AB, Bastin D, Olanubi O, Tennakoon G, Boucher DM, Ng J, Ardolino M, Auer RC. Market M, et al. Among authors: boucher dm. Front Immunol. 2020 Jun 23;11:1512. doi: 10.3389/fimmu.2020.01512. eCollection 2020. Front Immunol. 2020. PMID: 32655581 Free PMC article. Review.
Cancer stem cells as the relevant biomass for drug discovery.
Winquist RJ, Furey BF, Boucher DM. Winquist RJ, et al. Among authors: boucher dm. Curr Opin Pharmacol. 2010 Aug;10(4):385-90. doi: 10.1016/j.coph.2010.06.008. Epub 2010 Jul 12. Curr Opin Pharmacol. 2010. PMID: 20630801 Review.
Factors influencing development of new therapeutics for oncology.
Winquist RJ, Boucher DM. Winquist RJ, et al. Among authors: boucher dm. Curr Opin Pharmacol. 2010 Aug;10(4):353-5. doi: 10.1016/j.coph.2010.06.011. Epub 2010 Jul 14. Curr Opin Pharmacol. 2010. PMID: 20634136 No abstract available.
Proof of Principle for Local Delivery of a c-Met Inhibitor.
Li H, Kadiyala I, Briggs M, Shawgo R, Reda K, Patel R, Tanner K, Berlioz-Seux F, Furey B, Hurter P, Boucher DM. Li H, et al. Among authors: boucher dm. J Pharm Sci. 2018 Mar;107(3):856-862. doi: 10.1016/j.xphs.2017.10.025. Epub 2017 Oct 26. J Pharm Sci. 2018. PMID: 29107043
Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970.
Hall AB, Newsome D, Wang Y, Boucher DM, Eustace B, Gu Y, Hare B, Johnson MA, Milton S, Murphy CE, Takemoto D, Tolman C, Wood M, Charlton P, Charrier JD, Furey B, Golec J, Reaper PM, Pollard JR. Hall AB, et al. Among authors: boucher dm. Oncotarget. 2014 Jul 30;5(14):5674-85. doi: 10.18632/oncotarget.2158. Oncotarget. 2014. PMID: 25010037 Free PMC article.
23 results